Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced ...

Creative Biolabs is strengthening its lipid-based delivery portfolio with enhanced lipid nanoparticle (LNP) and liposome engineering capabilities designed to support the growing demand for RNA ...

Practicing ophthalmologists have an amazing legacy of catalyzing innovation to enhance our ability to retain, restore and ...

Immuron Engages Pullan Consulting to Advance IMM-529 Partnering Strategy; Immuron is seeking a partner to support clinical development through regulatory approval and ...

Recent data published in NEJM demonstrates that CRISPR gene-editing therapy achieves complete clinical efficacy endpoints in ...

Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...

Healthcare veteran Dr Douglas Williams discusses the impact of recent political upheaval in the US and the prospect of major ...

ALP Bio is developing an AI-powered platform that helps drug developers identify immune-related risks earlier in the ...

VERAXA Biotech (NASDAQ: VRXA) announced the initiation of cell line development for its lead BiTAC(R) T-cell engager ...

Getting it over the finish line was a labor of love—and now, more than five years after her death, the lab of former Sloan ...

Trinity Health Of New England has announced its intent to become a member of the Dana-Farber Cancer Institute Cancer Care Collaborative.

Manhattan Mental Health Counseling (MMHC) is an online therapy practice that takes insurance serving New York State. Its ...